Actively Recruiting
DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Led by Yunnan Cancer Hospital · Updated on 2025-01-01
135
Participants Needed
1
Research Sites
87 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To prospectively collect medical images and clinical data related to esophageal cancer using 4D Free Breathing DCE-MRI technology, to evaluate the image quality in the diagnosis of esophageal cancer, and to predict the efficacy of preoperative neoadjuvant chemoradiotherapy for esophageal cancer.
CONDITIONS
Official Title
DCE-MRI Based on 4D Free Breathing for Predicting Preoperative Neoadjuvant Chemoradiotherapy for Esophageal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be 18 years of age and older
- First diagnosis of esophageal squamous cell carcinoma confirmed by histopathological biopsy
- Clinical stage is cT1b to cT2 with positive lymph nodes; or clinical stage is cT3 to cT4 any lymph node status (thoracic esophageal cancer or esophagogastric junction cancer)
- No contraindications to MRI examination
You will not qualify if you...
- Have other primary tumors
- Image quality does not meet diagnostic criteria
- Do not cooperate with the inspection
- Have received prior chemoradiotherapy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yunnan Cancer Hospital
Kunming, Yunnan, China
Actively Recruiting
Research Team
R
ruiling Yang
CONTACT
Z
zhenhui Li
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here